INNATE PHARMA (EPA:IPH) Innate Pharma SA, a biopharmaceutical company developing first-in-class drugs targeting the innate immune system, today announced a turnover of 5.1 million euros for the first nine months of 2007
Transparency directive : regulatory news
06/11/2007 17:30
source : webdisclosure.com